Delivery Order SPE2DB25D7067-SPE2DB25FSVCE

Award Date 5/18/25
Potential Completion Date 5/19/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,385.21 firm fixed-price contract is for the delivery of MOVIPREP POWDER PACKETS, and has an ultimate completion date of May 30, 2025. The contract is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide MOVIPREP Powder Packets. The contract has a firm fixed price of $1,130.94 and a period of performance through October 25, 2024. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVIPREP POWDER PACKETS. The $3,019.54 firm fixed-price contract has an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical product, with a ceiling value of $1,770.38 and a performance period extending through June 13, 2025. The contract is not designated as a set-aside and was awarded on a full and open competition basis. AmerisourceBergen Drug Corp is the prime...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of MOVIPREP POWDER PACKETS, a pharmaceutical product, with a potential value of $3,467.31 and a completion date of March 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a ceiling value of $2,880.36 and a completion date of June 11, 2025. The contract is a firm-fixed-price delivery order, which indicates it is a specific order under a larger contract vehicle. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,037.20 firm fixed-price delivery order is for the supply of MOVIPREP POWDER PACKETS, with a performance period through May 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MOVIPREP POWDER PACKETS, a medical supply product, with a ceiling value of $2,501.30. The contract is a Firm Fixed Price Delivery Order, with a completion date of May 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,828,006 units of MOVIPREP POWDER PACKETS, a pharmaceutical product, at a firm fixed price of $2,807.92. The order has an ultimate completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,662.58 firm fixed-price delivery order is for the supply of MOVIPREP powder packets, with a performance period ending on May 9, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D7067
    Indefinite Delivery Contract
  • SPE2DB25D7067-SPE2DB25FSVCE
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,155.30, is for the delivery of MOVIPREP POWDER PACKETS and has a period of performance through May 19, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is not designated as a set-aside and is awarded on a firm fixed-price basis.

Generated 8/17/25, 9:42 AM